glp-1 drug market news today Novo cuts prices 70%, but semaglutide revenue could grow in 2026 GLP-1 Drugs and Consumer Preferences:

They serve structural and informational purposes rather than catalytic ones

This limited vascularity means tendons heal slowly and incompletely under normal circumstances

PMID 10940457

March 25 Product: AstraZenecas Ultomiris Indication: Neuromyelitis optica spectrum disorder Another rare disease, neuromyelitis optica spectrum disorder (NMOSD), saw a new approval Monday as the FDA greenlit AstraZenecas Ultomiris for patients positive for anti-AQP4 antibodies

Advances in quantitative bioanalysis of oligonucleotide biomarkers and therapeutics

It fights damage that makes your skin look tired, helping it get brighter and smoother